Pharma
Mutant Spike Proteins & Antigens for SARS-CoV-2 Variant Research
These reagents can be used by researchers to evaluate the efficacy of the antibodies and identify targets for development of improved therapeutic drugs and vaccines
President of the Pistoia Alliance: “Let’s Not Wait Another 100 Years to Collaborate”
Breakthroughs in vaccine development achieved in just 10 months show value of working together
ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement
ZeClinics is applying CRISPR technology to create gene edited zebrafish disease models
BioIVT Unveils COVID-19 Panel to Accelerate Vaccine-Generated Immune Response Research
Panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples
Arctoris Celebrates 5th Anniversary and Launches Its Expanded Robotic Platform Ulysses
Through end-to-end automation, the company’s unique technology platform rapidly delivers reliable, reproducible, and fully auditable datasets
FairJourney Biologics Group Introduces Flow Eighteen38 for Protein Production and Antibody Characterization Services
Flow Eighteen38 will provide purified proteins and data to accelerate the success of antibody projects
Patient-Derived Human Primary Cancer Cells
AMSBIO’s range of primary human cancer cells are available for specific tumor types, both primary and metastasis
Immudex Launches dCODE Dextramer® (RiO), a New Reagent Compatible with BD Rhapsody™ Single Cell Analysis System
These DNA barcoded MHC Dextramer® reagents are designed to be compatible with the BD Rhapsody™ system to be used for multiplexing